FKBP12 depletion leads to loss of sarcoplasmic reticulum Ca(2+) stores in rat vas deferens.
The immunophilin 12-kDa FK506 binding protein (FKBP12) stabilizes intracellular Ca(2+) release channel (CRC) activity in different tissues. In this work, the presence of FKBP12 in rat vas deferens (RVD) and its possible contribution to RVD function was investigated. Treatment under appropriate pH, temperature, and ionic conditions was used to strip FKBP12 from CRC binding sites; Western blotting revealed FKBP12 in control but not in treated homogenates. Disruption of the FKBP12-CRC complex in RVD decreased the Ca(2+) content of sarcoplasmic reticulum (SR) by increasing Ca(2+) leakage through the ryanodine receptor (RyR3 isoform) but not through 1,4,5-inositol trisphosphate receptors (IP(3)R1 and IP(3)R3 isoforms). The decrease of SR Ca(2+) content was not related to inhibition of SERCA ATPase. It seems that dissociation of FKBP12-RyR leads to conformational changes in RyR that make it difficult for ryanodine to access its binding site. Rapamycin, which is commonly used as a pharmacological tool to disrupt the FKBP12-RyR complex, decreased phenylephrine-induced contractions in RVD epididymal halves. The data suggest that FKBP12 is expressed in RVD in a labile association with RyR3. Disruption of the FKBP12-RyR3 complex may lead to modifications of RVD physiology and in consequence may compromise male fertility.
Scaramello
Christianne B V
CB
Laboratório de Farmacologia Bioquímica de Tecidos Musculares, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil.
Muzi-Filho
Humberto
H
Zapata-Sudo
Gisele
G
Sudo
Roberto T
RT
Cunha
Valéria do M N
Vdo M
D000818:Animals; D002118:Calcium / Q000378:metabolism; D008297:Male; D010656:Phenylephrine / Q000494:pharmacology; D051381:Rats; D019837:Ryanodine Receptor Calcium Release Channel / Q000378:metabolism; D012519:Sarcoplasmic Reticulum / Q000378:metabolism*; D020123:Sirolimus / Q000494:pharmacology; D022061:Tacrolimus Binding Protein 1A / Q000378:metabolism / Q000502:physiology*; D014649:Vas Deferens / Q000187:drug effects
D019837:Ryanodine Receptor Calcium Release Channel; D010656:Phenylephrine; D022061:Tacrolimus Binding Protein 1A; D002118:Calcium; D020123:Sirolimus